Big Tech & Digital Health

Amazon Puts Amwell Co-Founder in Charge of Healthcare Unit

By Intent.Health Team May 28, 2026
Intent Health AI Data Flow

What’s happening

Amazon appointed an Amwell co-founder to lead its healthcare division after a longtime executive departed.

The appointment signals Amazon’s continued push into:

What’s changing / Business impact

This organizational realignment introduces new tactical shifts for tech-driven care:

Why this matters

Amazon has spent years trying to establish a beachhead in healthcare but has faced persistent organizational challenges successfully scaling its healthcare business operations.

This aggressive executive hire shows that big tech still views healthcare as a massive, non-negotiable long-term commercial opportunity, proving that leadership changes may signal major strategic restructuring.
Pharma & R&D

Lilly’s Mounjaro Outperforms Other GLP-1 Drugs in Some Diabetes Patients

By Intent.Health Team May 29, 2026
Intent Health AI Data Flow

What’s happening

Mounjaro from Eli Lilly and Company showed stronger results than competing GLP-1 medicines in some patients with type 2 diabetes.

The study suggested better blood-sugar control and treatment outcomes for certain groups of patients.

What’s changing / Business impact

The findings strengthen Lilly's position in the highly competitive diabetes and obesity drug market.

Why this matters

GLP-1 medicines have become one of the biggest pharmaceutical markets in the world because they are used for both diabetes and weight management.